Engaging Patients in Medicines Regulation: A Tale of Two Agencies Posted on September 30, 2019June 21, 2021 by Hannah Faulkner Engaging Patients in Medicines Regulation: A Tale of Two Agencies
Giving Patients a Sense of Belonging Posted on September 18, 2019July 9, 2021 by Hannah Faulkner Giving Patients a Sense of Belonging
Patient preferences for using mobile technologies in clinical trials Posted on September 11, 2019February 11, 2025 by Hannah Faulkner Patient preferences for using mobile technologies in clinical trials
PEC Meeting Summary – September 2019 Posted on September 1, 2019February 6, 2025 by Hannah Faulkner PEC Meeting Summary – September 2019
Resources to assist in the transition to a single IRB model for multisite clinical trials Posted on September 1, 2019February 11, 2025 by Hannah Faulkner Resources to assist in the transition to a single IRB model for multisite clinical trials
Viewpoint: Stronger Regulations Are Necessary to Weed Out ‘Digital Snake Oil’ From Wearables, Apps Posted on August 22, 2019June 21, 2021 by Hannah Faulkner Viewpoint: Stronger Regulations Are Necessary to Weed Out ‘Digital Snake Oil’ From Wearables, Apps
FDA Affirms Interest in Promoting Decentralized Clinical Trials Posted on August 12, 2019June 21, 2021 by Hannah Faulkner FDA Affirms Interest in Promoting Decentralized Clinical Trials
Master Protocol Value Proposition Guide Posted on June 25, 2019February 6, 2025 by Hannah Faulkner Master Protocol Value Proposition Guide
Appendix 2: Mentoring and Knowledge-Sharing Examples Posted on June 8, 2019February 6, 2025 by Hannah Faulkner Appendix 2: Mentoring and Knowledge-Sharing Examples
Case Study: Returning Value to Participants without Compromising Study Integrity Posted on June 7, 2019February 6, 2025 by Hannah Faulkner Case Study: Returning Value to Participants without Compromising Study Integrity
